JBIO vs XERS
Comparison between Jade Biosciences Inc (JBIO, Company) and Xeris Biopharma Holdings Inc (XERS, Company).
Both JBIO and XERS are from the Healthcare sector.
5-Year PerformanceXERS has outperformed JBIO, delivering a return of +29.1% compared to -41.7%
JBIO vs XERS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
JBIO vs XERS - Historical Returns
Returns include dividend reinvestment.
JBIO vs XERS - Annual Returns (2018 - 2026)
Returns include dividend reinvestment.
| Year | JBIO | XERS |
|---|---|---|
| 2026 | +68.15% | +13.33% |
| 2025 | -79.69% | +126.88% |
| 2024 | -87.85% | +49.67% |
| 2023 | -16.28% | +109.82% |
| 2022 | +168.07% | -52.67% |
| 2021 | -48.36% | -44.82% |
| 2020 | N/A | -26.57% |
| 2019 | N/A | -59.71% |
| 2018 | N/A | -15.92% |
JBIO vs XERS Drawdown Comparison
The maximum drawdown for JBIO was -99.22%, occurring on Jun 13, 2025. This drawdown has not yet recovered.
The maximum drawdown for XERS was -96.22%, occurring on Jan 5, 2023. This drawdown has not yet recovered.
The current JBIO drawdown is -97.26%. The current XERS drawdown is -69.41%.
| Rank | JBIO | XERS |
|---|---|---|
| #1 | -99.22% Apr 1, 2024 - Jun 13, 2025 | -96.22% Sep 10, 2018 - Jan 5, 2023 |
| #2 | -68.61% Dec 12, 2022 - Apr 1, 2024 | -17.12% Jul 24, 2018 - Aug 14, 2018 |
| #3 | -63.86% Jun 30, 2021 - Aug 1, 2022 | -10.98% Jun 21, 2018 - Jul 20, 2018 |
| #4 | -42.73% Aug 12, 2022 - Dec 12, 2022 | -7.87% Aug 14, 2018 - Aug 22, 2018 |
| #5 | -4.56% Aug 5, 2022 - Aug 12, 2022 | -3.41% Aug 23, 2018 - Sep 7, 2018 |
| #6 | N/A | -3.07% Jul 20, 2018 - Jul 24, 2018 |
Correlation
Correlation between JBIO and XERS is -0.73 which considered as a strong negative correlation - the stocks tend to move in opposite directions.
Select Stocks to Compare
More Comparisons
Compare with similar stocks